Stay updated on KD025 Efficacy and Safety in cGVHD Clinical Trial
Sign up to get notified when there's something new on the KD025 Efficacy and Safety in cGVHD Clinical Trial page.

Latest updates to the KD025 Efficacy and Safety in cGVHD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.4.2 is displayed and the previous government-funding status notice (v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding notice at the top of the page and updated the Publications section with the ROCKstar study Blood article (2021) revision 3.4.1, replacing the earlier 3.4.0 citation.SummaryDifference0.4%

- Check28 days agoChange DetectedMinor UI and metadata updates include showing the glossary, a capitalization change in labels such as 'Last Update Submitted that Met QC Criteria'/'Last Update Submitted that met QC Criteria', the capitalization of 'No FEAR Act Data', and a revision bump to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. This is a minor version update that does not change the study details or page content.SummaryDifference0.0%

- Check64 days agoChange DetectedDifference2%

- Check78 days agoChange DetectedAdded the ROCKstar Study citation (Blood, 2021) to the Publications section. Removed the original Blood 2021 entry that has an Erratum published in Blood in 2022.SummaryDifference0.0%

Stay in the know with updates to KD025 Efficacy and Safety in cGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KD025 Efficacy and Safety in cGVHD Clinical Trial page.